• About us
• Contact

Advertisement

Organisation › Details

Visikol Inc.

Visikol is a CRO focused on advanced drug discovery that is leading the fields of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. *

 

	Start	2020-05-07 existent
	Group	Sartorius (Group)
	Industry	mass cytometry services
	Person	Johnson, Michael (Visikol 202005 CEO)
	Street	53 Frontage Road Shelbourne Building, Suite 120
	City	08827 Hampton, NJ
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Fluidigm Corporation. (5/7/20). "Press Release: Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services". South San Francisco, CA.
		Record changed: 2025-04-06

Advertisement

More documents for Sartorius (Group)

• [1] Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen....
• [2] Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen....
• [3] Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam....
• [4] Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford....
• [5] Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen....
• [6] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
• [7] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
• [8] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....
• [9] Sartorius AG. (8/17/23). "Press Release: Sartorius and Repligen Corporation Launch Integrated System with Biostat STR and XCell ATF for Upstream Process Intensification". Göttingen....
• [10] Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.